CSI Market
Sign In | Register

Cerevel Therapeutics Holdings Inc (CERE) Annual Balance Sheets

Annual · GAAP · USD millions
Access CERE quarterly Balance Sheets →
Balance sheet data covering Cerevel Therapeutics Holdings Inc–Aug 31 2015 offers a view into how Dec 31 2023's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Aug 31 2015)
Assets
Cash & cash equivalent416.47
Available-for-sale Securities, Debt Securities, Current MA574.50
Cash & Short-term Investments990.00
Accounts receivable0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current15.97
Total Current Assets1,006.94
Equipment/Property/Plant Net25.65
Long-term investments185.20
Other Assets, Noncurrent7.00
Operating Lease Right Of Use Asset20.13
Other Long Term Assets-
Total Assets1,243.30
Liabilities
Accounts Payable, Current AC11.86
Accrued Liabilities And Other Liabilities76.91
Other Liabilities, Current3.40
Billings in Excess of Cost, Current LI0.00
Total Current Liabilities92.18
Convertible Debt, Noncurrent LO337.42
Total Long-term Debt337.42
Deferred Rent Credit, Noncurrent DE0.00
Other liabilities, Noncurrent139.95
Operating Lease Liability Current3.40
Operating Lease Liability Noncurrent27.79
Noncurrent Financing Liability56.08
Total Liabilities569.55
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock2,072.55
Retained Earnings / Accumulated Deficit-1,400.60
Defined Benefit Plan and Other0.00
Other Equity1.77
Common Stockholder's Equity673.75
Total Stockholder's Equity673.75
Liabilities & Stockholder's Equity1,243.30
4 historic quarters locked

Sign in to unlock the full Cerevel Therapeutics Holdings Inc balance sheet history.

Sign In Create Free Account

About Cerevel Therapeutics Holdings Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: February 27, 2024
  • Source: cere-20231231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-021078

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.